Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme

NCT05908669 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT05908669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05908669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 25, 2023
Completion date
December 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme